Objectives The purpose of this review is to analyse the trend in papers related with Korean Medicine Treatment after musculoskeletal disorder surgery. Methods We reviewed Korean Medicine papers by searching Korean web databases 'Korea Traditional Knowledge Portal', 'Scientific and Technological Information Integration Service (NDSL)', 'Academic Research Information Service (RISS)', 'Korea Medical Informati on Portal (OASIS)'. We classified the papers by the year of publishment, the title of journals, the type of study, surgery region, chief complain after surgery, main treatment, periods after surgery, assessment for outcomes. Results 1. Korean Medicine treatment after musculoskeletal disorder surgery has received more attention than in the past and there are attempts to do various studies besides the case reports. 2. 41 research papers were divided in to 3 original articles, 3 review articles, 35 case reports. But almost presented a low level of evidence. 3. Pain was the most common symptom after the musculoskeletal disorder surgery. Pain should be the primary goal of Korean rehabilitation treatment after musculoskeletal disorder surgery. 4. Assessment tools for outcome were concentrated in questionnaries, VAS and NRS. In order to evaluate better, it is necessary to evaluate the overall condition of the patient such as the quality of life evaluation and patient satisfaction. Conclusions In this study, we expect that the development and clinical application of Korean rehabilitation treatment program after musculoskeletal disorder surgery will be actively pursued.

No abstract

No abstract

OBJECTIVES OBJECTIVESAlzheimer's disease (AD) is the most common form of dementia and is characterized clinically by a gradual decline in cognitive function, an increasingly neuropsychiatric and behavioral disturbances. Until recently, the treatment targeting neurodegenerative chain reaction has not shown clear results. And cholinesterase inhibitors have improved some cognitive function, it was not a satisfactory result. In this situation, studies have shown that inflammation of the brain can be the cause of AD. The aim of this study was to measure and compare the levels of CRP and fibrinogen in patients with AD, Mild cognitive impairment (MCI), normal control (NC) groups and to investigate the correlations between blood-based inflammatory factors and cognitive functions.

No abstract